Alphatec Holdings, Inc. (ATEC)
7.06
-0.29
(-3.95%)
USD |
NASDAQ |
Nov 12, 16:00
7.12
+0.06
(+0.85%)
Pre-Market: 09:09
Alphatec Holdings Enterprise Value : 1.621B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.621B |
| November 11, 2026 | 1.665B |
| November 10, 2026 | 1.611B |
| November 09, 2026 | 1.670B |
| November 06, 2026 | 1.679B |
| November 05, 2026 | 1.734B |
| November 04, 2026 | 1.808B |
| November 03, 2026 | 1.684B |
| November 02, 2026 | 1.659B |
| October 30, 2026 | 1.618B |
| October 29, 2026 | 2.282B |
| October 28, 2026 | 2.294B |
| October 27, 2026 | 2.205B |
| October 26, 2026 | 2.210B |
| October 23, 2026 | 2.242B |
| October 22, 2026 | 2.280B |
| October 21, 2026 | 2.204B |
| October 20, 2026 | 2.204B |
| October 19, 2026 | 2.135B |
| October 16, 2026 | 2.142B |
| October 15, 2026 | 2.214B |
| October 14, 2026 | 2.139B |
| October 13, 2026 | 2.198B |
| October 12, 2026 | 2.263B |
| October 09, 2026 | 2.175B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.125B |
| October 07, 2026 | 2.110B |
| October 06, 2026 | 2.155B |
| October 05, 2026 | 2.182B |
| October 02, 2026 | 2.076B |
| October 01, 2026 | 2.056B |
| September 30, 2026 | 2.121B |
| September 29, 2026 | 2.092B |
| September 28, 2026 | 2.043B |
| September 25, 2026 | 2.054B |
| September 24, 2026 | 2.024B |
| September 23, 2026 | 2.040B |
| September 22, 2026 | 2.086B |
| September 21, 2026 | 2.062B |
| September 18, 2026 | 2.063B |
| September 17, 2026 | 2.079B |
| September 16, 2026 | 2.112B |
| September 15, 2026 | 2.137B |
| September 14, 2026 | 2.167B |
| September 11, 2026 | 2.124B |
| September 10, 2026 | 1.859B |
| September 09, 2026 | 1.881B |
| September 08, 2026 | 1.912B |
| September 04, 2026 | 1.952B |
| September 03, 2026 | 1.933B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.182B |
| Abbott Laboratories | 213.21B |
| AngioDynamics, Inc. | 485.22M |
| AtriCure, Inc. | 2.760B |
| Baxter International, Inc. | 19.33B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.471M |
| Revenue (Quarterly) | 221.17M |
| Total Expenses (Quarterly) | 226.64M |
| EPS Diluted (Quarterly) | -0.0348 |
| Gross Profit Margin (Quarterly) | 62.30% |
| Profit Margin (Quarterly) | -2.47% |
| Earnings Yield | -7.97% |
| Normalized Earnings Yield | -6.922 |